Nominations can be made for three RCVS Honours: the Queen’s Medal, the Golden Jubilee Award and Honorary Associateship.
The Queen’s Medal was introduced in 2013 and is the highest honour that the College can bestow upon a veterinary surgeon in recognition of those who have achieved a highly distinguished career and outstanding achievements. Nominations can be made by any Member of the RCVS in respect of another veterinary surgeon. The 2016 winner of the award was Professor Randolph Richards who was honoured for his contribution to the development of aquaculture in Scotland.
The Golden Jubilee Award was introduced in 2011 to mark the 50th anniversary of the first RCVS training course for veterinary nurses and now recognises those nurses who are taking a leadership role within the profession. The 2016 winner of the award was Louise O’Dwyer who was recognised for her pioneering role within the profession. Nominations can be made by either veterinary nurses or veterinary surgeons in respect of a veterinary nurse.
Nominations can also be made for Honorary Associateship which is eligible for those who, while not veterinary surgeons or nurses, have made a significant impact in the veterinary field. Previous winners have included scientists, farmers, farriers, educationalists and journalists. This year an Honorary Associateship was awarded to Professor David Lane for his support in launching the College’s Certificate in Advanced Veterinary Practice.
Further information about making nominations for each of these awards, including nominations forms, can be found at www.rcvs.org.uk/honours.
The deadline for nominations is Friday 16 September 2016 and all awards will be bestowed at RCVS Day 2017 in July next year.
Those with questions about making a nomination can contact Peris Dean, Executive Secretary, on p.dean@rcvs.org.uk.
SRD remains a significant problem for the swine industry1. Associated production losses include 30-70% morbidity, a mortality rate of 4-6% (and even higher in severely affected units), decreased feed efficiency and reduced growth rates2.
Zactran contains gamithromycin. Merial says this bactericidal azalide rapidly accumulates in target lung tissue in less than 30 minutes, where it reaches and exceeds the MBC* for SRD pathogens for an extended period, helping to relieve clinical signs and minimise lung damage.
Zactran has a dose rate of 1ml per 25kg in pigs, administered by intramuscular injection.
The product is available in three pack sizes: 50ml glass bottle and 100ml and 250ml polypropylene shock-resistant bottles, and has a 3 year shelf-life.
References
*MBC: Minimum Bactericidal Concentrations. MBC is the lowest concentration of drug which reduces bacterial counts by 99.9% (CVMP/627/01)
Hosted by Chris Dixon, veterinary ophthalmologist and director at Veterinary Vision Ophthalmic Referrals, the Back to Basics series highlights key aspects to consider when examining a patient with an ocular disorder.
Each 15 minute video covers different aspects of the ocular examination, including practical tips for performing an external and internal ocular exam, optimal use of the ophthalmoscope, and how to approach and manage two common ocular conditions in dogs: corneal ulceration and keratoconjunctivitis sicca.
In the first video of the series, Chris discusses how to perform an external ocular examination, and demonstrates some key ocular reflex and response tests, including the menace response, dazzle reflex, and pupillary light reflex.
Chris said: "This series of videos aims to help vets learn how to perform the fundamental techniques of ophthalmic examination, hopefully enabling them to spot potentially degenerative conditions earlier. The videos have been created in partnership with Bayer as part of their ongoing commitment to training, and aim to help ensure that chronic conditions, such as keratoconjunctivitis sicca (KCS), or dry eye, are diagnosed and treated early."
Hannah Watts, Group Product Manager at Bayer said: "Ocular conditions are commonly encountered in practice, and early diagnosis of conditions such as keratoconjunctivitis sicca (KCS) is so important; with this in mind, the aim of these videos is to assist vets in their approach to the canine ocular examination, in order to allow them to feel confident in diagnosing and managing common ocular conditions."
The first video is available below. Don't forget that you can use the 'Claim CPD' button above this story to claim time spent watching it towards your annual CPD requirement.
The videos have been launched as part of the RemendTM Vision Matters campaign.
uiOVleUalo
Sean Wensley, President of the British Veterinary Association, said: "The research released today reflects the seriousness of the health problems associated with English bulldogs that our members are seeing in practice. Revision of breed standards, to include evidence-based limits on physical features such as muzzle shortness, and full consideration of other approaches such as outcrossing, are now needed to ensure high risk breeds, such as the English bulldog, do not continue to suffer unnecessarily.
"Vets are reporting concerning trends in dog health and welfare linked to the rise in ownership of brachycephalic breeds, such as bulldogs, and we are unequivocal in the need for all those with roles to play – including vets, breeders, breed societies, the pet-buying public as well as others – to take action to combat the health problems that brachycephalic breeds experience due to extreme conformation. These issues include severe lifelong breathing difficulties, corneal ulcers, skin disease, a screw-shaped tail which is linked to painful spine abnormalities, and the inability to give birth naturally.
"As part of their pre-purchase research, prospective dog owners should consider the health harms perpetuated in dogs by purchasing brachycephalic breeds and choose a healthier alternative breed, or crossbreed, instead, and local veterinary practices are ideally placed to give this advice. Brachycephalic dogs should not be seen as cute or desirable, rather as dogs predisposed to a lifetime of poor health, and English bulldogs should not be hailed as a national symbol for the UK where animal welfare is strongly valued.
"Vets have a duty to always prioritise the best interests of their pet patients, which, for affected animals, can involve performing surgical procedures to correct conformational disorders. They have a concurrent duty to be part of initiatives that aim to address the health and welfare of a breed beyond the individual affected animal.
"This is why BVA promotes the importance of vets submitting data on caesarean sections and conformation-altering surgery to the Kennel Club, to improve the future of dog health and welfare."
The new tool is part of a package that also includes posters and SMS texts to support veterinary practices in raising awareness of gastric ulcers to horse owners.
Equine Gastric Ulcer Syndrome (EGUS) is a serious and common condition and any type of horse can be at risk.1 EGUS can have a profound impact on a horse’s condition and performance and can be life threatening in foals. It is a challenging condition to diagnose as the clinical signs are often vague and not always present.1
Gastroscopy is the only method currently available for a definitive diagnosis. Of the two types of disease equine squamous gastric disease is graded on a numeric scale with 1 being the least severe and 4 being the most serious. Equine glandular gastric disease can be very varied in terms of location and type so grading this disease on a score system is no longer recommended. Instead it is now usually described in terms of location, severity and appearance.2
The new tool has been designed to help vets to map the area affected by gastric disease and record the details in an accessible format. This information, together with treatment and management recommendations, can be shared easily with the client. Posters explaining gastric ulceration have been designed to help increase awareness and understanding of EGUS amongst horse owners.
Zoetis says effective treatment usually involves a combination of management and medical treatments. UlcerGold is indicated to treat and prevent the recurrence of gastric ulcers in horses, administered once-daily for 28 consecutive days at the full dose of 4mg/kg bodyweight followed by the reduced dose of 1mg/kg bodyweight for a further 28 days.3 It contains omeprazole, a proton pump inhibitor that suppresses gastric acid secretion.3,4 One syringe contains enough UlcerGold for a daily dose for a horse weighing up to 700kg. It can be used for foals as young as four weeks of age that weigh over 70kg and for breeding stallions.
Organisations including British Veterinary Association (BVA) and the Society of Practising Veterinary Surgeons (SPVS) also responded to the consultation on behalf of members.
The College’s Education Department is now in the process of analysing the consultation responses.
Christine Warman, Head of Education at the RCVS, said: "We are very pleased with the number of responses we have received to this consultation which demonstrates what an important issue CPD, and our approach to it going forward, is for the profession. I am also glad that there was a good split of responses between veterinary surgeons and veterinary nurses as it is important we get as wide a range of views as possible from a wide range of individuals. I’d like to thank everyone who took the time to give us their views.
"Over the coming weeks we will be going through each response with a view to preparing proposals on the next steps for our CPD Working Party’s September meeting."
Proposals are expected to go to the Education Committee and to VN Council in October and then to the November meeting of RCVS Council.
Each week, the email will cover a different topic concerning either dairy, beef, sheep, pigs, poultry or gamebirds. The information, which is personalised with the practice details, can then be forwarded to clients who have an interest in that particular area, for example a resource on mastitis could be sent to dairy farmers and their staff.
Mike Howe, Veterinary Director at NADIS said: "We are confident that practices will recognise the value of the NADIS material and utilise this free service, as it will not only help to raise disease awareness, but will also assist vets in encouraging farmers to think about optimising their herd health. All NADIS materials promote veterinary health planning as the most effective way of preventing disease, and promote the vet’s role on the farm."
The resources also offer an opportunity for farmers and their staff to gain a City & Guilds unit of accreditation. A module can be completed by passing all the quizzes from each disease resource, providing an easy and flexible way for farmers and farm employees to gain recognised qualifications.
For more information, visit: www.nadis.org.uk.
Rabbit Viral Haemorrhagic Disease variant (RVHD2) is a variation of the already recognised Rabbit Viral Haemorrhagic Disease (RVHD1). Vaccines for the original strain of RVHD do not appear to offer long term protection against RVHD2, however vaccines for this new strain are now available in the UK and can be purchased through three UK wholesalers (NVS, Centaur and Henry Schein Animal Health) or direct from the suppliers in Europe. There have been supply issues with this vaccination, however these are hoping to be remedied soon.
RVHD2 is more variable in its rate of disease progression than RVHD1, with presentation ranging from sudden death (with or without bleeding from the orifices), to a longer disease course of three to nine days, increasing the risk of unwell rabbits being brought into practices and in turn increasing the risk of transmission to other pet rabbits. Until vaccination becomes more routine, biosecurity in practices is key to prevent the disease from spreading.
Sean Wensley, BVA President, said: "Although the risk of a rabbit contracting RVHD2 appears highest in situations where rabbits are kept in large groups with regular new additions, such as at breeders or rescue centres, we encourage all owners to speak to their vet about vaccinating their rabbits against RVHD2.
"Veterinary advice from The Rabbit Welfare Association and Fund (RWAF) has stated that the spread of RVHD2 may be facilitated by its apparent slower disease progression compared to RVHD1, and research suggests that we can expect to see RVHD2 starting to predominate in the UK’s wild rabbits over RVHD1 in the next five years or so."
John Chitty, BSAVA Vice President, said: "BSAVA would encourage practices to talk to rabbit owning clients about RVHD2 vaccines, and where there is deemed sufficient risk recommend the vaccine along with the essential vaccination against Myxomatosis – and it should be noted that this must not be done within two weeks of vaccination against RVHD2."
BVZS President and veterinary pathologist Mark Stidworthy said: "It is clear from post mortem examinations and PCR testing over the last 18 months that RVHD2 is now geographically widespread in the UK and all rabbits should be considered at risk from this potentially devastating disease."
Due to recent media coverage of RVHD2, vets may be contacted by concerned owners seeking advice on how to prevent their rabbits contracting this disease - further to vaccinating, vets should recommend rabbits are kept separate from any other rabbits they do not usually interact with; are prevented from having contact with wild rabbits and do not attend any rabbit shows unless already vaccinated.
For a detailed Q&A on RVHD2 from Richard Saunders MRCVS, veterinary advisor to the RWAF, including information on sourcing effective vaccines, visit www.rabbitwelfare.co.uk and click RVHD2 - Filavac Vaccine – FAQs on the home page.
Photo: Larry D. Moore CC BY-SA 3.0.
The procedure is called radiocatheter ablation. It's used regularly in humans but there are only three or four centres in the world that perform the procedure routinely on veterinary patients and Pedro is the only veterinary cardiologist currently performing it in the UK.
DVS says the procedure can achieve a cure for previously incurable conditions, without the need for further medical treatment with drugs that have potential side effects. It involves inserting catheters into veins in the legs and neck and then guiding them into the heart. Electrical signals can be recorded to show where the abnormal heartbeats are generated ('mapping'). Once this is achieved, heat is used to destroy the tiny abnormal area of the heart muscle and make the arrhythmia disappear ('zapping'). Recovery is straightforward and the condition can be completely cured.
Jake, a three-year-old Labrador Retriever, is one of seven dogs that have been cured by Pedro and the team so far.
Jake suffered from life-threatening cardiac arrhythmia, causing his heart to beat at over 250 beats per minute for prolonged periods. Such an elevated heart rate cannot be sustained for long and may result in damage to the heart muscle. Jake had been diagnosed a number of months ago and initially responded to anti-arrhythmic drugs. However, the drugs stopped working and his heart was sustaining damage and showing early signs of weakness. The radiocatheter ablation cured his condition completely and he can now lead a normal healthy life.
Jake’s owner, Mrs Chapman from Staffordshire, said: "We would like to thank everyone at Davies Veterinary Specialists for looking after Jake during his three day stay in April 2016. Special thanks to Pedro Oliveira and his cardiac team for operating on Jake and correcting his heart condition. Jake is no longer taking any medication and has made a full recovery. We now have a much happier, more energetic Labrador, ready for walks and play at every opportunity. Jake seems to have a smile on his face everyday now and is enjoying life to the full."
Pedro said: "We have treated seven patients in the past year, all with success and without complications. Unfortunately a significant proportion of candidates for these procedures are in desperate situations with failing hearts and after all drugs have failed before they reach us. Hopefully, with greater awareness of the availability of this procedure, we can treat more patients before it gets to be that bad."
Clive Elwood, Managing Director of Davies Veterinary Specialists said: "This is a great example of how our team of specialists can deliver ground-breaking and innovative care, which makes a real difference for both patients and their loving owners."
Pedro is happy to discuss the suitability of cases with vets managing dogs with arrhythmias. Contact him at cardiology@vetspecialists.co.uk or find out more at www.vetspecialists.co.uk
The Easy to Give Awards are designed to recognise the commitment made by pharmaceutical companies in making it easier to give prescription-only medications to cats; recognising that medicines which are easier to give make life less stressful for vets, owners and cats alike and ensure better compliance.
Each Easy to Give Award is decided by a feline expert veterinary panel taking into account feedback from their clients. And the winners are ...
These companies will be granted the use of the Easy to Give logo on advertising to the veterinary world. These bring the total number of Easy to Give awards presented, since their inception in 2005, to 39.
International Cat Care also announced the winners of the Cat Friendly Awards, which recognise other products that have made a real difference to cat wellbeing and welfare.
For more details on the work of the charity go to www.icatcare.org.
Metacam 40 mg/ml solution for injection for cattle and horses contains 40 mg/ml of meloxicam, and is available in either 50 ml or 100 ml presentations. It is approved for subcutaneous or intravenous use in cattle, and intravenous use in horses.
Boehringer says the introduction comes on the back of a recent large-scale landmark study that found adding Metacam to standard antibiotic therapy for mastitis resulted in a greater first-service conception rate, fewer inseminations required to conceive and a higher probability of pregnancy by 120 days post-calving when compared to cows receiving antibiotic therapy alone1.
Boehringer Ingelheim’s technical manager Kath Aplin said: "By reducing the pain and inflammation caused by mastitis and other conditions, the use of Metacam 40 can result in improvements in cattle health and welfare, and may help limit any reduction in feed intakes. This is central to efficient herd management and productivity."
The company adds that new Metacam 40 mg/ml formulation offers a lower volume dose compared to the existing 20 mg/ml presentation, giving vets more flexibility in their use of Metacam.
The College says it will be promoting its Find a Vet search tool and its new Practice Standards Scheme (PSS) at the event, which runs from Thursday 4 to Sunday 7 August. It will also be giving career advice for prospective veterinary surgeons and veterinary nurses.
The College’s Find a Vet search tool was relaunched earlier this year, allowing users to search for a veterinary surgeon, veterinary nurse or veterinary practice all in one place. The tool also includes new features such as displaying a practice’s visiting information (including opening hours and car parking); enabling users to ‘get directions’ via Google Maps; advertising a practice’s PSS accreditations and awards; and returning individual profile pages for veterinary surgeons and veterinary nurses.
To promote the free search tool the College will be encouraging visitors to take part in its Find a Vet dice game, as well as hosting a random draw photo competition which will encourage members of the public to find and photograph one of our veterinary surgeons or veterinary nurses who will be lost in the grounds of Blenheim Palace.
Another of the College’s promotional focuses is the new PSS. The new PSS is designed to provide a greater focus on how practices use their resources to create a positive outcome for patients and clients, and allows for practices to distinguish the areas in which they excel through its awards system. The College says it is using BBC Countryfile Live to raise the profile of PSS and make animal owners more aware of the various available accreditation levels.
Ahead of the event, the RCVS is running social media competitions to give away 15 free pairs of tickets: on Facebook (/TheRCVS); Twitter (@RCVS_UK); and its new Instagram account (@thercvs). The competitions ends Friday 29 July, with winners being announced that day at 5pm. Tickets will allow entry on Thursday 4, Friday 5, and Sunday 7 August.
NOAH’s Office Manager Joanne Jeffs said: "We know more people are accessing the site using mobile technology and in order that the site can be viewed more easily on mobile phones and tablets as well as traditional desktops, we needed to move the whole complex set of data to a new web platform.
"This is only one of the advantages of the move – it will enable us to finalise our Compendium app, for example, and further down the line will enable more bespoke information access to become available via an API* feed – and we needed to take this major step for progress to be made.
"The most important thing was to maintain the integrity of the data – prescribers and users of animal medicines rely on its accuracy to make their prescribing decisions and guide responsible use. We know this has been done.
She added: "With the move, we know there are some post launch issues that we are addressing. We are working on those as quickly as we can. We know users need to print datasheets, for example and this function will soon be back online. We welcome all feedback and thank all our users for their patience.
www.noahcompendium.co.uk
James Hutchings, Head of Sales for Bimeda UK, said: "The launch of Tetroxy Vet highlights our ongoing commitment to providing UK veterinarians with a choice of high quality veterinary pharmaceuticals at a fair price."
Bimeda says the benefits of Tetroxy Vet include:
Tetroxy Vet is available in a 100ml pack size.
Chris has been an elected member of Council since 2009 and, during this time, has served on the Education Committee, the Examinations Appeal Committee and the Operational Board as Chair of the Education Committee and Junior Vice-President.
He graduated with a veterinary degree from the University of Glasgow at the relatively advanced age of 30 having first attained a degree in Agricultural and Environmental Science from the University of Newcastle. Following graduation he worked in a mixed practice in Herefordshire before buying an equine and companion animal practice in West Berkshire, which currently employs five veterinary surgeons and five support staff.
In his maiden speech, Chris called on veterinary surgeons and veterinary nurses to be proud of themselves as people who are committed to the welfare of animals in their care and to not be so hard on themselves.
He also outlined several areas that he would like to prioritise during his presidential year. These included delivering the priorities set out in the Vet Futures Action Plan, exploring bringing veterinary paraprofessionals into the College’s regulatory remit, driving forward the College’s international profile and dealing with blame and fear culture in the profession.
He said: "I’ve seen first-hand in Africa and India what the delivery of veterinary care can do for the welfare of animals in these regions and the wellbeing of people that frequently depend upon them. As one of the richest nations in the world we will further investigate what we can do, through knowledge transfer and support, to help raise the standards of veterinary care in developing countries.
"Sadly we often hear that there are vets and nurses who live in fear of the RCVS. This is something of which I am personally ashamed. Being particularly mindful of the role that fear and anxiety play in mental health, I will do everything I can to replace this fear... I will encourage all hardworking vets and nurses, whichever field they are in, to wear their [MRCVS] ‘badge’ with pride. Feel good about what you do, feel great about what you do."
Chris’ first official duty upon receiving the presidential chain of office from outgoing President Dr Bradley Viner, was to welcome the new Junior Vice-President Professor Stephen May. He also praised Bradley for his calm authority, humour and wisdom throughout his year as RCVS President.
The event will again be held at Loseley Park in Surrey, on Friday 9th and Saturday 10th June 2017.
New for 2017, VET Festival will be introducing an Internal Medicine stream which will cover the themes of Emergency & Critical Care, Endocrinology, Cardiology, Reproduction, Respiratory and Small Furries.
There will also be a new stream dedicated to Rehabilitation, which will join Orthopaedics, Neurology, Oncology and Soft Tissue, Nursing and Management and Motivation. Delegates are free to join any lecture at any stream and attendance to VET Festival will contribute towards their CPD.
Professor Noel Fitzpatrick, who conceived VET Festival, said "The aim of the VET Festival is very simple – to provide the best veterinary education in the world so as to ensure the best standard of care for our animal friends, delivered in the most exciting environment on Planet Earth where all of the finances return to helping the animals.
"I believe that people who love companion animals will be aware of our need to receive the very highest level CPD and that both delegates and exhibitors deserve real value for money. I’m determined that the festival is firmly focussed on the greater good of the welfare of animals entrusted to our care – and on maintaining the fire in our bellies that we first had when we signed up for this vocation.
"My dream is to create a Glastonbury for Veterinary Medicine in my lifetime and that VET Festival will be the most interesting, innovative, exciting, dynamic, informative, career-enhancing and personally fulfilling veterinary CPD in the world.
"I have absolutely zero doubt that within five years VET Festival will be a key event in the veterinary education calendar for one simple reason, and that is we reinject the happiness into the reason why we started this journey in the first place. We want delegates to feel love for their profession and respect for everything that they do.
"Most importantly I want people to feel fulfilled because every single day that they go to work as a veterinary professional, they don’t really do it just for monetary gain. They do it because they want to make a difference. When the delegates leave VET Festival, I want them to know that they have made that difference."
Brian Topper, Managing Director of Centaur Services, one of the official partners of VET Festival 2016, said: "I think VET Festival is awesome. It’s different than anything we have done in the UK and US veterinary industry. It’s very timely as people are getting tired of the traditional route to education. This is a great opportunity and we are very happy to participate. I have been in the industry for 20 years and I have seen nothing like VET Festival. Wherever VET Festival goes, we will be here!"
Velactis (cabergoline) is a POM marketed by Ceva Animal Health, used in the herd management programme of dairy cows as an aid in abrupt drying-off, by reducing milk production.
The product was authorised through the European Medicines Agency (EMA) in December 2015 and was first sold in the UK in April 2016.
The VMD says it has been made aware of reports of serious adverse events, predominantly occurring in Denmark, involving recumbency (lying down and unable to rise) and some deaths. Most adverse events occurred within 8 to 24 hours following product administration. Anecdotal evidence suggests that hypocalcaemia treatments may be successful in reversing clinical signs.
Ceva has decided to stop further distribution of the product in Europe voluntarily, pending the outcome of further investigations to assess a possible causal link between the product and the adverse events reported.
The VMD, EMA, other agencies throughout Europe and the MAH are working closely to monitor the situation.
The VMD highlights that due to the nature and use of the product there is no risk to human health or consumer safety.
Vets and dairy farmers are strongly encouraged to report any adverse events associated with use of Velactis to the VMD using its online reporting form or directly to Ceva for further investigation by the MAH as necessary.
At the start of June, the British Veterinary Association (BVA), British Cattle Veterinary Association (BCVA), Goat Veterinary Society (GVS), and Sheep Veterinary Society (SVS) welcomed the announcement that bluetongue (BTV-8) vaccine would be available by mid-July to support farmers and smallholders in managing the risk of a bluetongue outbreak predicted to reach mainland UK by late summer.
Since the Defra risk assessment indicates a high risk by late summer of a BTV incursion from France, veterinary associations have been involved in discussions with government, farmers’ representatives and manufacturers to ensure vaccine is available to meet potential demand particularly in the south of England where risk is highest. The situation remains under constant review by Defra as the disease develops and the weather warms up, promoting midge activity.
Pharmaceutical companies MSD and Zoetis announced that batches of vaccine would be available from mid-July, which Defra has just confirmed.
Vets across the UK are also contributing to the Joint campaign Against Bluetongue (JAB), helping to make farmers aware of the risk, clinical signs and what action to take, through speaking at local JAB information events and displaying posters and leaflets in practices.
While welcoming the announcement of vaccine availability in June, veterinary organisations also sought clarification about the cost and the amount of vaccine likely to be available in July and thereafter. This information is now available.
BVA President Sean Wensley said: "We welcome the announcement that vaccine will be available in time to meet potential demand. This disease seriously affects animal health and welfare as well as the productivity of livestock, and vaccination is the key control."
Photo by Fourrure (http://www.boulesdefourrure.fr) [CC BY-SA 2.0], via Wikimedia Commons
The Association says that the qualification is intended to give vets the chance to conduct clinical research relating to their work – in particular vets working in general practice.
The qualification, validated by Nottingham Trent University, is aimed at people who already have any accredited Postgraduate Certificate (60 credits at Level 7) relevant to some aspect of veterinary medicine or surgery.
The programme is based on a further 1,200 study hours and could be flexibly achieved in two years of part-time study or up to five years, depending on the project type and an individual’s availability.
Frances Barr, BSAVA Academic Director, has developed the most extensive CPD programme in the 60-year history of the organisation. She said: "It’s a really significant addition to the BSAVA CPD programme and another step supporting lifelong learning, which we hope will have a very positive impact on the profession."
"Anyone who has an interest in clinical research – such as evaluating risk factors for a particular disease or factors that might influence an outcome – will find this an ideal way to satisfy their enquiring mind.
"If they have the motivation to keep developing a deeper understanding, we can provide encouragement and support for how to answer those clinical questions."
The Masters programme starts with online study into the principles of clinical research, which students will then apply to their own research project.
Students will be allocated a ‘matched’ supervisor who will provide project advice and guidance, plus the BSAVA team will be on hand to ensure ongoing support and encouragement.
The programme starts in January 2017 and applications open this October.
Frances added: "It can sometimes be quite difficult to get going in research when you don’t know how to do it, so having taken the first step in a supported environment we hope many will go on to do extend their clinical research ambitions.
"BSAVA’s mission is to support vets at every stage of their careers. There are often limited opportunities for practitioners to conduct clinical research, so this is a qualification that enables vets to do just that."
For more information, please contact the BSAVA Education team at masters@bsava.com
VetSurgeon Editor Arlo Guthrie said: “The original setup, which reorders a list of available positions by distance from a location, works very well when you know where you want to work.
"The new VetSurgeon Jobs Map, on the other hand, is ideal for when you’re not sure where exactly you want to work, and just want to know what’s out there.
"We’ve also added a 'World Jobs Map' so that there’s a quick and easy way to see any jobs outside the UK, such as those currently advertised in Bahrain, South Africa and Ireland."
The VetSurgeon Jobs Map is the latest in a string of new features added since a small charge was introduced for advertising jobs in May, including Find our jobs on VetSurgeon, Share & Reward and the VetSurgeon Locums Map. The same features have also been added over on VetNurse Jobs, too.
Arlo said: "Now that we charge for advertising on VetSurgeon Jobs, I’m interested in only one thing, which is offering both job seekers and recruiters the best service available anywhere."
The new 10ml (10-dose) and 100ml (100-dose) packs of Ingelvac PRRS EU are available now, and will complement the existing 50ml (50-dose) packs.
Callum Blair MRCVS, Swine Brand Manager at Boehringer Ingelheim, said: "Nobody likes to end up with part used bottles of any vaccine that then have to be discarded. The addition of Ingelvac PRRS EU 10-dose and 100-dose packs will provide choice for different sized units and help reduce wasted doses."
For more information, visit www.prrs.com.
During the 60 days before to 30 days after calving, dairy cows experience a dip in their natural immunity, leaving them especially vulnerable to important diseases such as mastitis2, metritis3 and retained placenta.4 With serious cost consequences and implications for cow welfare and productivity, this makes the transition period one of the most challenging yet vital periods for vets to manage with dairy clients.
Imrestor (pegbovigrastim injection) is a pegylated form of the naturally occurring protein cytokine, bovine Granulocyte Colony Stimulating Factor (bG-CSF). Elanco says it helps restore the cow’s natural defences by increasing the number and restoring the function of neutrophils, the primary type of white blood cell that recognizes and kills harmful bacteria.
Fiona Anderson, Technical Vet at Elanco, said: "It’s no secret that a successful transition period is vital for maximising productivity in the next lactation, yet we are still ‘firefighting’ common transition diseases like mastitis rather than focusing on their true cause."
"Vets are under increasing pressure to adopt a more proactive approach, not least to reduce the use of antibiotics in livestock but with few credible alternatives. This can be challenging in dairy herds, particularly around calving when cows are susceptible to multiple disease challenges while their defences are low. Imrestor helps to restore a cow’s own natural immunity and strengthen her ability to defend against infection by a range of mastitis pathogens – thus helping to protect the cow against mastitis when she needs it most."
Available in pre-filled, single-dose syringes, Imrestor is administered with two injections – one seven days prior to the anticipated date of calving and the other within 24 hours after calving – with neither injection requiring a withdrawal period.
Kingsley Baxendale, Ruminant Marketing Manager at Elanco Animal Health said: "It can be extremely frustrating for vets to see their dairy farmers struggling with the stress and hassle of dealing with increased numbers of sick cows during calving; they have enough to deal with at the moment. We’re delighted that Imrestor can provide vets with a tool to help decrease the negative consequences associated with immune-related diseases like mastitis and maximise their herds’ lactation potential."
As part of the launch of Imrestor, Elanco also announced its new 'Pledge To Protect' initiative to encourage vets and farmers to make a pledge symbolising their commitment to address immune suppression in their dairy cows.
The number of pledges will be tracked using a life-sized 2D cow model, pictured above. For each pledge, which can be made online or at events, Elanco will make a £5 donation to The Royal Agricultural Benevolent Institution (R.A.B.I), which supports farmers in difficulty. As a thank you for showing support, all pledgers will automatically be entered into a weekly prize draw.
To find out more about using Imrestor and how you can make your pledge, visit www.vital90days.co.uk.
It is hoped the findings, which were unveiled at the House of Commons yesterday, will enable the welfare priorities of the UK’s 800,000 horses to be addressed.
This is the first time welfare organisations, breeders, the equine industry and the veterinary profession have come together to agree on a strategy to best improve the welfare of horses in the UK.
The equine welfare study found the welfare needs of many horses are not currently being met and the report has highlighted four welfare priorities.
Dr Siobhan Mullan, Research Fellow in Animal Welfare Science, Ethics and Law at the University of Bristol and one of the report’s authors, said: "Bringing together the views of people associated with horses in England and Wales has provided an overview of horse welfare, from the day-to-day concerns of equine caregivers to identifying four priority challenges to equine welfare.
"This research has also identified how equine welfare can be improved, by addressing both the priority challenges, and a wider set of industry and horse-based needs."
Roly Owers, World Horse Welfare Chief Executive, added: "This research report provides a vital insight to the UK’s equine sector, mapping out the welfare landscape from a wide range of sector experts and stakeholders.
"In order for World Horse Welfare and others to most effectively address the welfare challenges facing UK equines, we need to better understand today’s welfare priorities and this research will provide a valuable guide to help in driving the focus of our educational initiatives and resources over the next few years.”
The priority welfare challenges and solutions outlined in the report are:
Unresolved stress/pain behaviourProblems associated with unresolved stress/pain behaviour affect large numbers of horses, often for long durations with variable severity of suffering caused to individual horses.
More academic research is needed to fully understand the links between behaviour, stress and pain, and objective measures of stress and pain in horses should be developed. Vets, riding instructors, the Pony Club, riding clubs and the equine press have a role in educating horse caregivers about signs of stress and pain and the appropriate responses. Academics and experts also have a role in tackling this issue through evaluating the effectiveness of intervention programmes.
Inappropriate nutritionOverfeeding and obesity are the main welfare problems associated with nutrition and affect large numbers of horses, often for a long time with varying severity of suffering.
Vets have a key role in tackling the problems associated with inappropriate nutrition. A consistent approach by all vets is needed, to prevent horse owners choosing vets that don’t challenge owners about their horses’ nutrition. Feed companies can also play an important role in tackling this issue, although many feed companies already offer appropriate nutrition for a range of horses and exercise situations. Better owner education, based on existing good research, would ensure the right nutritional choices are made for individual horses.
Inappropriate stabling /turnoutWelfare of horses is compromised when the amount of time spent at pasture/stabled does not meet their individual needs, when they are kept in social isolation or when they are exposed to unsuitable grazing conditions. Welfare problems associated with incorrect stabling/turnout affect large numbers of horses for a long time with variable levels of suffering.
Although all horse owners make choices relating to the amount and type of stabling and turnout experienced by their horses, livery yard owners could play a role in addressing this issue. For example, by encouraging different approaches to management, including group housing and the use of all-weather turnout facilities. Strengthening legislation is another possible way for improvement but a ‘one size fits all’ approach would be inappropriate. For example, for some horses, turn out to pasture may not always be suitable.
Delayed deathHorses may be kept alive inappropriately resulting in firstly, prolonging welfare problems, such as continued suffering of a horse in pain. This affects relatively large numbers of horses, for short periods of time with the severity of suffering often being severe. Secondly, an increased risk of suffering, for example where horses are unwanted by their owners, become low value and subsequently aren’t cared for well.
One way for improvement could be by putting pressure on the EU to make changes to the passport regulations. In particular, legislation changes that would enable horses who had received medications, including Phenylbutazone, to be slaughtered to enter the human food chain after a six month withdrawal period. In addition, challenging negative attitudes of horse owners towards timely euthanasia is important.
The research, undertaken over a four year period, was to understand the welfare status of horses in England and Wales, identify priority welfare issues and explore horse owner and industry experts’ perceptions of these issues.
Stakeholders from across the equine industry contributed to the research: from vets to farriers and welfare charities to governing body representatives, participants represented a wide-reaching cross section of horse care roles and responsibilities.
Amanda Melvin, Senior Product Manager, said: "We’re very excited about this approval as it will allow us to build on the success of our Bravecto chewable tablets for dogs and provide veterinarians and cat owners with another tool in the fight against ticks and fleas. Being able to offer a full 12 week protection means convenience for cat owners and improved compliance rates for veterinarians, so everyone benefits."
Bravecto is applied topically using the new "Twist’n’Use" pipette design which means the cap doesn’t need to be removed.
Full product details are described in the summary of product characteristics (SPC).
For more information, contact your MSD Animal Health representative.
The 3D dental model, which was produced with the help of veterinary dentist John Robinson, demonstrates the recommended method for sectioning and extracting teeth in cats and dogs.
An accurate representation of the animal’s mouth, the teeth are pre-sectioned, indicating how tooth crowns should be divided and where to cut the crown to achieve single root pieces.
Royal Canin's Veterinary Marketing Manager, Marianne Lomberg, said: "We are delighted to offer this new learning tool. These high quality and accurate models will be a valuable addition to the education resources available to veterinary schools and professionals – ultimately helping contribute to a higher standard of dental care available to cats and dogs."
Orders of £300 will receive one free model, orders of £500 will receive two free models.
For more information, contact your Royal Canin Veterinary Business Manager or visit www.vetportal.royalcanin.co.uk.